Finance

Lists
31R:FRA
Revive Therapeutics Ltd
€0,015
+25,00%
(+0,0030) 1D
24 Jul., 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 31R...
Open
€0,01
High
€0,02
Low
€0,01
Mkt. cap
10,46 m
Avg. vol.
34,00
Volume
8,00 k
52-wk high
€0,06
52-wk low
€0,00
Open
€0,01
High
€0,02
Low
€0,01
Mkt. cap
10,46 m
Avg. vol.
34,00
Volume
8,00 k
52-wk high
€0,06
52-wk low
€0,00
News stories
From sources across the web
About Revive Therapeutics Ltd
CEO-
Employees-
Founded2012
HeadquartersToronto, Ontario, Kanada
SectorPharmaceutical industry
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
336,32 k
200,14 k
283,25 k
242,05 k
Operating expense
336,39 k
220,13 k
283,30 k
463,87 k
Total operating expenses
336,39 k
220,13 k
283,30 k
463,87 k
Operating income
-336,39 k
-220,13 k
-283,30 k
-463,87 k
Other non operating income
73,85 k
-
-
-
EBT including unusual items
-9,60 m
-281,75 k
-238,72 k
-506,50 k
EBT excluding unusual items
-143,94 k
-281,75 k
-234,70 k
-506,50 k
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9,60 m
-281,75 k
-238,72 k
-506,50 k
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
277,00
-
-
Interest expense
-
-
-
-
Net interest expenses
-
277,00
-
-
Depreciation and amortization charges
62,00
46,00
48,00
47,00
EBITDA
-336,32 k
-220,08 k
-283,25 k
-463,82 k
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more